✦ LIBER ✦

O-153 Phase III randomised trial of doxorubicin based chemotherapy compared with platinum based chemotherapy in both limited and extensive stage patients

✍ Scribed by Baka, S.; Lorigan, P.; Papakotoulas, P.; Rehman, S.; Lau, S.; Anderson, H.; Finn, C.; Ashcroft, L.; Thatcher, N.

Book ID: 118572701
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 274 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80287-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III randomised trial of doxorubici

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

✍ Baka, S; Califano, R; Ferraldeschi, R; Aschroft, L; Thatcher, N; Taylor, P; Faiv 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Prognostic and Predictive Value of Tumor

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

✍ Loi, S.; Sirtaine, N.; Piette, F.; Salgado, R.; Viale, G.; Van Eenoo, F.; Rouas, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 313 KB

Zalutumumab plus best supportive care ve

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

✍ Jean-Pascal Machiels; Somasundaram Subramanian; Agnes Ruzsa; Gabor Repassy; Igor 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 315 KB

Randomised controlled trial comparing si

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

✍ Buda, A; Floriani, I; Rossi, R; Colombo, N; Torri, V; Conte, P F; Fossati, R; Ra 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

6570 POSTER Results for progression-free

6570 POSTER Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) are comparable when analysed by similar populations and methodology

✍ Sandler, A.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB